Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Augustin M, Reich K, Yamauchi P, Pinter A, et al. Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial. Br J Dermatol 2022 Jan 4. doi: 10.1111/bjd.20971.
PMID: 34981829


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016